Literature DB >> 3460737

The effect of food on the pharmacokinetics of ofloxacin.

M Verho, V Malerczyk, E Dagrosa, A Korn.   

Abstract

After oral administration of a single dose of ofloxacin (300 mg), with and without a standard breakfast, to 12 healthy male volunteers in an open, randomized crossover study, concentrations of the unchanged drug were estimated at various times in serum and urine, over 28 hours and 48 hours, respectively. Each dose was followed by a wash-out period of 1 week. Ofloxacin concentrations were determined using high pressure liquid chromatography (HPLC): parallel determinations using a microbiological assay were in close agreement. Maximum serum concentrations (Cmax) of ofloxacin, after fasting and with breakfast, respectively, were 3.7 and 3.1 micrograms/ml (HPLC, median values). The corresponding areas under the serum concentration-time curves (AUC0-28) were 29.9 and 24.5 micrograms/ml. The lower values of Cmax and AUC0-28 found after food intake were statistically significant (p less than 0.05) but not clinically relevant when compared to the fasting values. Time to reach Cmax and terminal elimination half-life (t1/2 beta) were not significantly affected by food intake: t1/2 beta was calculated as 5.3 and 5.9 hours (HPLC, median values), fasting and with breakfast, respectively. Urinary recovery (after 48 hours: 72% and 74%, respectively) was also not significantly affected by food intake, and urinary concentrations of ofloxacin remained far above 1 microgram/ml, i.e. above the minimum inhibitory concentration (MIC90) for most bacterial strains, for at least 48 hours after drug administration. General tolerability was good; no side-effects were reported.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3460737     DOI: 10.1185/03007998609110436

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  11 in total

Review 1.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy.

Authors:  Brahma N Singh; Bimal K Malhotra
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

3.  The effect of food or milk on the absorption kinetics of ofloxacin.

Authors:  M N Dudley; C R Marchbanks; S C Flor; B Beals
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 4.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

5.  Pharmacokinetics of ofloxacin in patients on haemodialysis treatment.

Authors:  A Dörfler; W Schulz; F Burkhardt; M Zichner
Journal:  Drugs       Date:  1987       Impact factor: 9.546

6.  Pharmacokinetics of ofloxacin after single and multiple intravenous infusions in healthy subjects.

Authors:  R Farinotti; J H Trouvin; V Bocquet; N Vermerie; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

7.  Effect of enteral feeding with ensure on oral bioavailabilities of ofloxacin and ciprofloxacin.

Authors:  B A Mueller; D G Brierton; S R Abel; L Bowman
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

8.  Effect of a fat- and calcium-rich breakfast on pharmacokinetics of fleroxacin administered in single and multiple doses.

Authors:  J S Bertino; A N Nafziger; M Wong; L Stragand; C Puleo
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

9.  Effects of traditional Chinese medicines on pharmacokinetics of levofloxacin.

Authors:  T Hasegawa; K Yamaki; I Muraoka; M Nadai; K Takagi; T Nabeshima
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

Review 10.  Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Monk; D M Campoli-Richards
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.